Search Results - "Helmut Rainer"

Diversity and Discrimination in the Classroom. Working Paper 32177

Authors: National Bureau of Economic Research (NBER) Dan Anderberg Gordon B. Dahl et al.

Source: National Bureau of Economic Research. 2024.

Peer Reviewed: N

Descriptors: Foreign Countries, Ethnic Groups, Intergroup Relations, Trust (Psychology), Student Diversity, Peer Relationship, Immigrants, Cultural Differences, Classroom Environment, Ethnic Stereotypes, Racial Discrimination

Geographic Terms: Germany

Access URL: https://www.nber.org/papers/w32177

The role of leukemia-derived B7-H1 (PD-L1) in tumor–T-cell interactions in humans

Authors: Salih, Helmut Rainer Wintterle, Sabine Krusch, Matthias et al.

Source: Experimental Hematology. Jul2006, Vol. 34 Issue 7, p888-894. 7p.

Release of MICB Molecules by Tumor Cells: Mechanism and Soluble MICB in Sera of Cancer Patients

Authors: Salih, Helmut Rainer Goehlsdorf, Dennis Steinle, Alexander

Source: Human Immunology. Mar2006, Vol. 67 Issue 3, p188-195. 8p.

Modulation of Natural Killer Cell Anti-Tumor Reactivity by Platelets.

Authors: Placke, Theresa Kopp, Hans-Georg Salih, Helmut Rainer

Source: Journal of Innate Immunity. Jun2011, Vol. 3 Issue 4, p374-382. 9p.

Glucocorticoid-Induced TNFR-Related (GITR) Protein and Its Ligand in Antitumor Immunity: Functional Role and Therapeutic Modulation.

Authors: Placke, Theresa Kopp, Hans-Georg Salih, Helmut Rainer

Source: Clinical & Developmental Immunology. 2010, p1-10. 10p. 1 Diagram.

Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers.

Authors: Walz, Juliane Sarah Kanz, Lothar Nelde, Annika et al.

Source: Leukemia & Lymphoma. Aug2018, Vol. 59 Issue 8, p1949-1958. 10p.

Expression of RANK-L and in part of PD-1 on blasts in patients with acute myeloid leukemia correlates with prognosis.

Authors: Schmohl, Joerg Uwe Nuebling, Tina Wild, Julia et al.

Source: European Journal of Haematology. Dec2016, Vol. 97 Issue 6, p517-527. 11p.

Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.

Authors: Kampa-Schittenhelm, Kerstin Maria Salitzky, Olaf Akmut, Figen et al.

Source: BMC Cancer. 1/16/2016, Vol. 16, p1-12. 12p. 2 Charts, 5 Graphs.

A "vicious cycle" of NK-cell immune evasion in acute myeloid leukemia mediated by RANKL?

Authors: Schmiedel, Benjamin Joachim Grosse-Hovest, Ludger Salih, Helmut Rainer

Source: OncoImmunology. May2013, Vol. 2 Issue 5, pe23850-1-e23850-3. 3p.

The wolf in sheep's clothing: Platelet-derived "pseudo self" impairs cancer cell "missing self" recognition by NK cells.

Authors: Placke, Theresa Kopp, Hans-Georg Salih, Helmut Rainer

Source: OncoImmunology. Jul2012, Vol. 1 Issue 4, p557-559. 3p.

The role of soluble and cell-surface expressed 4-1BB ligand in patients with malignant hemopoietic disorders.

Authors: Scholl, Nina Loibl, Julia Kremser, Andreas et al.

Source: Leukemia & Lymphoma. Mar2009, Vol. 50 Issue 3, p427-436. 10p. 2 Charts, 6 Graphs.

The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells.

Authors: Schmidt, Moritz Altdörfer, Vanessa Schnitte, Sarah et al.

Source: Neoplasia. Jul2019, Vol. 21 Issue 7, p653-664. 12p.

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy.

Authors: Walz, Simon Stickel, Juliane S. Kowalewski, Daniel Johannes et al.

Source: Blood. 9/3/2015, Vol. 126 Issue 10, p1203-1213. 11p.

Generation and Preclinical Characterization of a Fc-optimized GITR-Ig Fusion Protein for Induction of NK Cell Reactivity Against Leukemia.

Authors: Schmiedel, Benjamin Joachim Werner, Antje Steinbacher, Julia et al.

Source: Molecular Therapy. Apr2013, Vol. 21 Issue 4, p877-886. 10p.

RANKL Expression, Function, and Therapeutic Targeting in Multiple Myeloma and Chronic Lymphocytic Leukemia.

Authors: Schmiedel, Benjamin Joachim Scheible, Carolin Andrea Nuebling, Tina et al.

Source: Cancer Research. Jan2013, Vol. 73 Issue 2, p683-694. 12p.

Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells.

Authors: Placke, Theresa Örgel, Melanie Schaller, Martin et al.

Source: Cancer Research. Jan2012, Vol. 72 Issue 2, p440-448. 9p.

Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells.

Authors: Maurer, Stefanie Kropp, Korbinian Nepomuk Klein, Gerd et al.

Source: OncoImmunology. 2018, Vol. 7 Issue 2, pN.PAG-N.PAG. 1p.

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy.

Authors: Nelde, Annika Walz, Juliane Sarah Kowalewski, Daniel Johannes et al.

Source: OncoImmunology. 2017, Vol. 6 Issue 3, pN.PAG-N.PAG. 1p.

An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia.

Authors: Steinbacher J Baltz-Ghahremanpour K Schmiedel BJ et al.

Source: International journal of cancer [Int J Cancer] 2015 Mar 01; Vol. 136 (5), pp. 1073-84. Date of Electronic Publication: 2014 Jul 28.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases.

Authors: Todenhöfer T Hennenlotter J Schmiedel BJ et al.

Source: The Prostate [Prostate] 2013 Jan; Vol. 73 (2), pp. 162-8. Date of Electronic Publication: 2012 Jun 19.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE